TVRD — Tvardi Therapeutics, Inc.

TVRDTvardi Therapeutics, Inc.

NAS · US · Healthcare · Biotechnology · tvarditherapeutics.com

3.135USD-6.42%Mkt Cap: 29.65M USDP/E: —Last update: 2026-06-01

Tvardi Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of novel, oral, and small molecule therapies targeting signal transducer and activator of transcription 3 (STAT3) to treat…

Industry Peers

Biotechnology

VRTX

Vertex Pharmaceuticals Incorporated

Regeneron Pharmaceuticals, Inc.

Alnylam Pharmaceuticals, Inc.

40.10BUSDP/E 75.3

RVMD

Revolution Medicines, Inc.

Indicators:|

Key Statistics

Company

Market Cap29.65M USD

Enterprise Value6.90M USD

Revenue (TTM)—

Gross Profit—

Net Income (TTM)-18.21M USD

Revenue/Share—

Last Price3.135 USD

Fiscal Year EndDec 2025

MR QuarterMar 2026

Employees12

CountryUS

SectorHealthcare

IndustryBiotechnology

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)-1.48

PEG—

EV/EBITDA-0.23

EV/Revenue—

P/S—

P/B2.19

EPS (TTM)-0.27

EPS (Forward)-2.28

52W Range

2.7501% of range43.65

52W High43.65 USD

52W Low2.750 USD

Profitability

Gross Margin0.00%

Oper. Margin0.00%

EBITDA Margin0.00%

Profit Margin0.00%

ROE-86.96%

ROA-56.79%

Growth

Revenue Growth—

Earnings Growth—

Cash Flow & Leverage

Operating CF-23.50M USD

CapEx (TTM)—

FCF Margin—

FCF Yield-39.03%

Net Debt-24.81M USD

Net Debt/EBITDA0.85

Balance Sheet

Debt/Equity0.01

Current Ratio2.25

Quick Ratio2.22

Book Value/Sh1.546 USD

Cash/Share2.663 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Splits

Last Split1:3

Split DateApr 16, 2025

Analyst Consensus

Rating—

Target (Mean)8.167 USD

Target Range3.000 USD – 15.00 USD

# Analysts6

Ownership

Shares Out.9.38M

Float6.46M

Insiders34.64%

Institutions28.93%

Short Interest

Short Ratio11.6d

Short % Float5.25%

Short % Out.5.22%

Shares Short490.17K

Short (prev mo.)554.34K

Technical

SMA 503.403 (-7.9%)

SMA 20010.16 (-69.1%)

Beta—

S&P 52W Chg27.70%

Avg Vol (30d)42.75K

Avg Vol (10d)53.06K

Technical Indicators

RSI (14)42.9

MACD-0.0032

MACD Signal0.0744

MACD Hist.-0.0776

BB Upper4.331 USD

BB Middle3.726 USD

BB Lower3.121 USD

BB Width32.49%

ATR (14)0.2811 USD

Vol Ratio (20d)0.69x